Citing 528btc, Hyperliquid Strategies has received shareholder approval to merge with Sonnet BioTherapeutics and Rorschach I LLC, clearing the final hurdle for its transformation into a digital asset fund focused on HYPE tokens. The new entity plans to raise up to $1 billion and acquire at least $265 million in HYPE, with analysts expecting further token buybacks and increased liquidity demand.
Hyperliquid Strategies Approved for $1 Billion Fundraising and HYPE Token Reserves
币界网Share
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.